BackTaiwan Liposome Company Overview

Taiwan Liposome Company Current Cash

Track Taiwan Liposome Company's current cash ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$0.00
↓ 100.00% YoYΔ $-1.23B vs prior year quarter

Peer average

Loading

Taiwan Liposome Company Current Cash History

Loading

Taiwan Liposome Company vs. peers: Current Cash Comparison

Loading

Taiwan Liposome Company Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Taiwan Liposome Company (TLC) FAQ

Taiwan Liposome Company (TLC) currently reports a current cash of $0 as of June 2021. That compares with $1.2B in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Taiwan Liposome Company's current cash history and peer comparisons.

Taiwan Liposome Company's current cash decreased from $1.2B to $0 — a 100.0% year-over-year decrease (period ending June 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Taiwan Liposome Company reported $0 in current cash as of June 2021. That compares with $1.2B in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Taiwan Liposome Company, and consider following TLC for alerts when major investors trade the stock.

Taiwan Liposome Company is classified in the Healthcare sector. On current cash, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLC with unrelated industries.